Climb Bio to Present at Upcoming September 2025 Investor Conferences
Rhea-AI Summary
Climb Bio (Nasdaq: CLYM), a clinical-stage biotechnology company focused on immune-mediated disease therapeutics, has announced its participation in four major investor conferences in September 2025.
The company will participate in the Cantor Global Healthcare Conference (Sept 5), Baird Global Healthcare Conference (Sept 9), Morgan Stanley Annual Global Healthcare Conference (Sept 10), and Stifel Virtual Immunology and Inflammation Forum (Sept 10). Most events will feature fireside chats or presentations along with one-on-one investor meetings.
Live webcasts will be available through Climb Bio's investor relations website, with replays accessible for 30 days after each event.
Positive
- None.
Negative
- None.
News Market Reaction 11 Alerts
On the day this news was published, CLYM gained 4.20%, reflecting a moderate positive market reaction. Argus tracked a trough of -8.3% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $7M to the company's valuation, bringing the market cap to $169M at that time.
Data tracked by StockTitan Argus on the day of publication.
WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conferences detailed below.
Cantor Global Healthcare Conference
Location: New York, NY
Format: Fireside chat and one-on-one investor meetings
Date: Friday, September 5, 2025
Time: 10:55 a.m. ET
Baird Global Healthcare Conference
Location: New York, NY
Format: Fireside chat and one-on-one investor meetings
Date: Tuesday, September 9, 2025
Time: 4:20 PM p.m. ET
Morgan Stanley Annual Global Healthcare Conference
Location: New York, NY
Format: One-on-one meetings only
Date: Wednesday, September 10, 2025
Stifel Virtual Immunology and Inflammation Forum
Location: Virtual
Format: Presentation and one-on-one investor meetings
Date: Wednesday, September 10, 2025
Time: 10:30 a.m. ET
The live webcasts will be accessible via the “Investors and News” section of the Climb Bio website: https://ir.climbbio.com/. Webcast replays will be available on the Climb Bio website beginning approximately two hours after each webcast event and will be archived for at least 30 days.
About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit climbbio.com.
Investors and Media
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com
FAQ
When is Climb Bio (CLYM) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Climb Bio's (CLYM) September 2025 conference presentations?
Which investor conferences will Climb Bio (CLYM) attend in September 2025?
What type of company is Climb Bio (CLYM)?
